Yamashita T, Masuda N, Saji S, Araki K, Ito Y, Takano T, Takahashi M, Tsurutani J, Koizumi K, Kitada M, Kojima Y, Sagara Y, Tada H, Iwasa T, Kadoya T, Iwatani T, Hasegawa H, Morita S, Ohno S.
Trastuzumab, pertuzumab, and eribulin mesylate versus trastuzumab, pertuzumab, and a taxane as a first-line or second-line
treatment for HER2-positive, locally advanced or metastatic breast cancer: study protocol for a randomized controlled, non-inferiority, phase Ⅲtrial in Japan (JBCRG-M06/EMERALD).
Clinical trials, 2020;21：ePub.
Ishitobi M, Matsuda N, Tazo M, Nakayama S, Tokui R, Ogawa T, Yoshida A, Kojima Y, Kuwayama T, Nakayama T, Yamauchi H, Nakamura S, Tsugawa K, Hayashi N
Risk factor for ipsilateral breast tumor recurrence in Triple-negative or HER2-Positive breast cancer patients who achieve a pathologic complete response after neoadjuvant chemotherapy.
Annals of surgical oncology : the official journal of the Society of Surgical Oncology, 2020;28(5)：2545-2552.
Okada Y, Kobayashi M, Shinozaki M, Abe T, Kanemaki Y, Nakamura N, Kojima Y
Survival time and prognostic factors after whole-brain radiotherapy of brain metastases from of breast cancer.
Acta Radiologica Open, 2020;9(7) 1–8：1-8.
Goto Y, Tsugawa K, Furuya Y, Maezato M, Tagami Y, Ogawa Y, Saisu M, Yamazaki M, Kuramochi F
Behavior of Japanese women after being informed about the benefits and disadvantages of breast cancer screening: a questionnaire survey.
Breast Cancer, 2020;27：739-747.
Kubo M, Kumamaru H, Isozumi U, Miyashita M, Nagahashi M, Kadoya Ti, Kojima Y, Aogi K, Hayashi N, Tamura K, Asaga S, Niikura N, Ogo E, Iijima K, Tanakura K, Yoshida M, Miyata H, Yamamoto Y, Imoto S, Jinno H
Annual report of the Japanese Breast Cancer Society registry for 2016.
Breast Cancer, 2020;27(4)：511-518.
Okada Y, Abe T, Shinozaki M, Tanaka A, Kobayashi M, Gomi H, Nakamura N, Kojima Y
Evaluation of imaging findings and prognostic factors after whole-brain radiotherapy for carcinomatous meningitis from breast cancerA retrospective analysis.
medicine, 2020;99(31)：e21333.
Hayashi N, Kumamaru H, Isozumi U, Aogi K, Asaga S, Iijima K, Kadoya T, Kojima Y, Kubo M, Miyashita M, Miyata H, Nagahashi M, Niikura N, Ogo E, Tamura K, Tanakura K, Yamamoto Y, Yoshida M, Imoto S, Jinno H.
Annual report of the Japanese Breast Cancer Registry for 2017.
Breast Cancer, 2020;27(5)：803-809.
Ogiya R, Niikura N, Kumamaru H, Takeuchi Y, Okamura T, Kinoshita T, Aogi K, Anan K, Iijima K, Ishida T, Iwamoto T, Kawai M, Kojima Y, Sakatani T, Sagara Y, Hayashi N, Masuoka H, Yoshida M, Miyata H, Tsuda H, Imoto S, Jinno H
Breast cancer survival among Japanese individuals and US residents of Japanese and other origins: a comparative registry-based study.
Breast cancer research and treatment, 2020;184(5)：585-596.
Hayashi N, Yagata H, Tsugawa K, Kajiura Y, Yoshida A, Takei J, Yamauchi H, Nakamura S
Response and Prognosis of Docetaxel and Cyclophosphamide as Neoadjuvant Chemotherapy in ER+ HER2− Breast Cancer: A Prospective Phase Ⅱ Study.
Clinical breast cancer, 2020;20(6)：462-468.
Yamamoto Y, Yamashiro H, Toh U, Kondon N, Nakamura R, Kashiwaba M, Takahashi M, Tsugawa K, Ishikawa T, Nakayama T, Ohtani S, Takano T, Fujisawa T, Toyama T, Kawaguchi H, Mashino K, Tanino Y, Morita S, Toi M, Ohno S
Prospective observational study of bevacizumab combined with paclitaxel as first- or second-line chemotherapy for locally advanced or metastatic breast cancer: the JBCRG-C05 (B-SHARE) study.
Breast Cancer, 2021;28(1)：145-160.
② 症例報告
Kuji S, Kondo H, Ohara T, Deura I, Tozawa-Ono A, Migita O, Kawamoto H, Tsugawa K, Chosokabe M, Koike J, Maeda I, Suzuki N Value of adjuvant chemotherapy and informed microscopic examination for occult gynecologic cancer detected upon risk-reducing salpingo-oophorectomy after chemotherapy for BRCA 1/2-associsted breast cancer: a case report.
Japanese Journal of Clinical Oncology, 2021;51(3)：492-497.
Kojima Y, Tsugawa K
Single institute experience of treatment for metastatic HER positive breast cancer patients with trastuzumab deruxtecan.
第18回日本臨床腫瘍学会学術集会, 2021.
② 国際学会
Tajima S, Matsumoto N, Chosokabe M, Endo A, Naruki S, Doi M, Kishimoto K, Tsugawa K, Koike J
Intraductal nuclear inverse-polarity papillary lesions without bilayer structure: a report of two cases.
The 16th International Conference on Surgical Pathology & Cancer Diagnosis, 2020.
Tajima S, Matsumoto N, Naruki S, Doi M, Endo A, Chosokabe M, Kishimoto K, Tsugawa K, Koike J
Nuclear inverse polarity papillary lesion without myoepithelial cells in the breast Author and Co-author names.
Cancer Virtual 2020, 2020.
Tajima S, Matsumoto N, Chosokabe M, Endo A, Naruki S, Doi M, Kishimoto K, Tsugawa K, Takagi M, Koike J.
Nuclear Inverse Polarity Papillary Lesions with Lack Myoepithelial Cells:A Report of Two Cases.
International Congress on Biotechnology and Food Sciences, 2020.
